AOA Dx

AOA Dx is a biotech company that develops early-stage ovarian cancer diagnostic tests by analyzing ganglioside compositions in blood samples. It targets healthcare providers and clinical labs to improve detection accuracy and patient outcomes compared to current screening methods.